Healthcare >> CEO Interviews >> September 20, 1999
DOUGLAS HARRINGTON, M.D., Chief Executive Officer & President of
ChromaVision, brings over 18 years experience in the commercialization
of healthcare technology. Prior to joining the Company in December
1996, Dr. Harrington served as Chairman and President of Strategic
Business Solutions, Inc., a privately held company specializing in the
commercialization of biotechnology, and as a Principal in Douglas S.
Harrington and Associates, a strategic consulting firm. From 1992 to
1995, Dr. Harrington served as President of Nichols Institute, a
publicly traded healthcare laboratory services provider, now part of
Quest Diagnostics, Inc. Prior to 1992, Dr. Harrington held various
management positions with Nichols Institute including Vice President of
Operations and Medical Director. Dr. Harrington currently sits on the
Board of Directors, Advisory Board, or Scientific Advisory Board of
several other related healthcare and medical device companies. In
addition to his business experience, Dr. Harrington is an Associate
Professor of Clinical and Anatomic Pathology at the University of
Nebraska Medical Center and has authored over 80 peer-reviewed
publications. He received a Bachelor of Arts degree with distinction as
well as a Medical Degree from the University of Colorado with
specialties in Hematology and Anatomic & Clinical Pathology. He has
multiple professional affiliation memberships including the American
Medical Association, the American Society of Clinical Pathologists, the
College of American Pathologists and the International Academy of
Pathology Profile
company, enough to put us into perspective for what you then would
describe as your business and your company today?
Dr.
